These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

773 related items for PubMed ID: 26149228

  • 1. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery.
    Lee JY, Chung SJ, Cho HJ, Kim DD.
    Eur J Pharm Biopharm; 2015 Aug; 94():532-41. PubMed ID: 26149228
    [Abstract] [Full Text] [Related]

  • 2. Polyethylene glycol-conjugated chondroitin sulfate A derivative nanoparticles for tumor-targeted delivery of anticancer drugs.
    Lee JY, Park JH, Lee JJ, Lee SY, Chung SJ, Cho HJ, Kim DD.
    Carbohydr Polym; 2016 Oct 20; 151():68-77. PubMed ID: 27474544
    [Abstract] [Full Text] [Related]

  • 3. Reduction-sensitive micelles self-assembled from amphiphilic chondroitin sulfate A-deoxycholic acid conjugate for triggered release of doxorubicin.
    Liu H, Wu S, Yu J, Fan D, Ren J, Zhang L, Zhao J.
    Mater Sci Eng C Mater Biol Appl; 2017 Jun 01; 75():55-63. PubMed ID: 28415498
    [Abstract] [Full Text] [Related]

  • 4. Self-assembled nanoparticles based on chondroitin sulfate-deoxycholic acid conjugates for docetaxel delivery: Effect of degree of substitution of deoxycholic acid.
    Liu M, Du H, Zhai G.
    Colloids Surf B Biointerfaces; 2016 Oct 01; 146():235-44. PubMed ID: 27343846
    [Abstract] [Full Text] [Related]

  • 5. Self-assembled nanoparticles of reduction-sensitive poly (lactic-co-glycolic acid)-conjugated chondroitin sulfate A for doxorubicin delivery: preparation, characterization and evaluation.
    Wang XF, Ren J, He HQ, Liang L, Xie X, Li ZX, Zhao JG, Yu JM.
    Pharm Dev Technol; 2019 Jul 01; 24(6):794-802. PubMed ID: 30907676
    [Abstract] [Full Text] [Related]

  • 6. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.
    Li W, Yi X, Liu X, Zhang Z, Fu Y, Gong T.
    J Control Release; 2016 Mar 10; 225():170-82. PubMed ID: 26826304
    [Abstract] [Full Text] [Related]

  • 7. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y, Zhang J, Cheng R, Deng C, Meng F, Xie F, Zhong Z.
    J Control Release; 2015 May 10; 205():144-54. PubMed ID: 25596560
    [Abstract] [Full Text] [Related]

  • 8. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model.
    Alibolandi M, Sadeghi F, Abnous K, Atyabi F, Ramezani M, Hadizadeh F.
    Eur J Pharm Biopharm; 2015 Aug 10; 94():521-31. PubMed ID: 26170161
    [Abstract] [Full Text] [Related]

  • 9. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
    Han X, Li Z, Sun J, Luo C, Li L, Liu Y, Du Y, Qiu S, Ai X, Wu C, Lian H, He Z.
    J Control Release; 2015 Jan 10; 197():29-40. PubMed ID: 25449802
    [Abstract] [Full Text] [Related]

  • 10. Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy.
    Misra R, Sahoo SK.
    Eur J Pharm Sci; 2010 Jan 31; 39(1-3):152-63. PubMed ID: 19961929
    [Abstract] [Full Text] [Related]

  • 11. Angelica sinensis polysaccharide nanoparticles as a targeted drug delivery system for enhanced therapy of liver cancer.
    Zhang Y, Cui Z, Mei H, Xu J, Zhou T, Cheng F, Wang K.
    Carbohydr Polym; 2019 Sep 01; 219():143-154. PubMed ID: 31151511
    [Abstract] [Full Text] [Related]

  • 12. Chondroitin sulfate-hybridized zein nanoparticles for tumor-targeted delivery of docetaxel.
    Lee HS, Kang NW, Kim H, Kim DH, Chae JW, Lee W, Song GY, Cho CW, Kim DD, Lee JY.
    Carbohydr Polym; 2021 Feb 01; 253():117187. PubMed ID: 33278965
    [Abstract] [Full Text] [Related]

  • 13. Preparation and evaluation of reduction-responsive micelles based on disulfide-linked chondroitin sulfate A-tocopherol succinate for controlled antitumour drug release.
    Cai S, Xie X, Yuan Q, Ding J, Meng L, Li J, He M, Li W, Yu J.
    J Pharm Pharmacol; 2021 Sep 07; 73(10):1405-1417. PubMed ID: 34254648
    [Abstract] [Full Text] [Related]

  • 14. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin.
    Mezghrani O, Tang Y, Ke X, Chen Y, Hu D, Tu J, Zhao L, Bourkaib N.
    Int J Pharm; 2015 Jan 30; 478(2):553-68. PubMed ID: 25455765
    [Abstract] [Full Text] [Related]

  • 15. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
    Alibolandi M, Abnous K, Sadeghi F, Hosseinkhani H, Ramezani M, Hadizadeh F.
    Int J Pharm; 2016 Mar 16; 500(1-2):162-78. PubMed ID: 26802496
    [Abstract] [Full Text] [Related]

  • 16. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
    Li Q, Lv S, Tang Z, Liu M, Zhang D, Yang Y, Chen X.
    Int J Pharm; 2014 Aug 25; 471(1-2):412-20. PubMed ID: 24905776
    [Abstract] [Full Text] [Related]

  • 17. Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration.
    Jeong JY, Hong EH, Lee SY, Lee JY, Song JH, Ko SH, Shim JS, Choe S, Kim DD, Ko HJ, Cho HJ.
    Acta Biomater; 2017 Apr 15; 53():414-426. PubMed ID: 28216300
    [Abstract] [Full Text] [Related]

  • 18. Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery.
    Lee JY, Termsarasab U, Park JH, Lee SY, Ko SH, Shim JS, Chung SJ, Cho HJ, Kim DD.
    J Control Release; 2016 Aug 28; 236():38-46. PubMed ID: 27320169
    [Abstract] [Full Text] [Related]

  • 19. Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin.
    Cho HJ, Yoon IS, Yoon HY, Koo H, Jin YJ, Ko SH, Shim JS, Kim K, Kwon IC, Kim DD.
    Biomaterials; 2012 Feb 28; 33(4):1190-200. PubMed ID: 22074664
    [Abstract] [Full Text] [Related]

  • 20. Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment.
    Zhang B, Cheng G, Zheng M, Han J, Wang B, Li M, Chen J, Xiao T, Zhang J, Cai L, Li S, Fan X.
    Drug Deliv; 2018 Nov 28; 25(1):461-471. PubMed ID: 29426237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.